Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620124
Title:
Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury.
Authors:
Chen, Y-T; Yang, C-C; Zhen, Y-Y; Wallace, Christopher G ( 0000-0003-1897-9520 ) ; Yang, J-L; Sun, C-K; Tsai, T-H; Sheu, J-J; Chua, S; Chang, C-L; Cho, C-L; Leu, S; Yip, H-K
Abstract:
This study tested the hypothesis that cyclosporine (CsA)-supported syngeneic adipose-derived mesenchymal stem cell (ADMSC) therapy offered superior attenuation of acute ischemia-reperfusion (IR) kidney injury to either therapy alone.
Citation:
Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury. 2013, 4 (3):62 Stem Cell Res Ther
Publisher:
BioMed Central
Journal:
Stem Cell Research & Therapy
Issue Date:
31-May-2013
URI:
http://hdl.handle.net/11287/620124
DOI:
10.1186/scrt212
PubMed ID:
23726287
Additional Links:
https://stemcellres.biomedcentral.com/articles/10.1186/scrt212
Note:
This article is freely available online via Open Access. Click on the Additional Link above to access the full-text via the publisher's site.
Type:
Journal Article; Research Support, Non-U.S. Gov't
Language:
en
ISSN:
1757-6512
Appears in Collections:
Plastic & Reconstructive Surgery; pre-2014 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorChen, Y-Ten
dc.contributor.authorYang, C-Cen
dc.contributor.authorZhen, Y-Yen
dc.contributor.authorWallace, Christopher Gen
dc.contributor.authorYang, J-Len
dc.contributor.authorSun, C-Ken
dc.contributor.authorTsai, T-Hen
dc.contributor.authorSheu, J-Jen
dc.contributor.authorChua, Sen
dc.contributor.authorChang, C-Len
dc.contributor.authorCho, C-Len
dc.contributor.authorLeu, Sen
dc.contributor.authorYip, H-Ken
dc.date.accessioned2017-01-04T15:25:19Z-
dc.date.available2017-01-04T15:25:19Z-
dc.date.issued2013-05-31-
dc.identifier.citationCyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury. 2013, 4 (3):62 Stem Cell Res Theren
dc.identifier.issn1757-6512-
dc.identifier.pmid23726287-
dc.identifier.doi10.1186/scrt212-
dc.identifier.urihttp://hdl.handle.net/11287/620124-
dc.description.abstractThis study tested the hypothesis that cyclosporine (CsA)-supported syngeneic adipose-derived mesenchymal stem cell (ADMSC) therapy offered superior attenuation of acute ischemia-reperfusion (IR) kidney injury to either therapy alone.en
dc.language.isoenen
dc.publisherBioMed Centralen
dc.relation.urlhttps://stemcellres.biomedcentral.com/articles/10.1186/scrt212en
dc.rightsArchived with thanks to Stem cell research & therapyen
dc.subjectWessex Classification Subject Headings::Urology::Nephrology/Renal medicineen
dc.titleCyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury.en
dc.typeJournal Articleen
dc.typeResearch Support, Non-U.S. Gov'ten
dc.identifier.journalStem Cell Research & Therapyen
dc.description.noteThis article is freely available online via Open Access. Click on the Additional Link above to access the full-text via the publisher's site.en
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.